Important cytological findings for distinction between follicular variant and conventional papillary thyroid carcinoma, including noninvasive follicular thyroid tumors with papillary-like nuclear features.


Journal

Endocrine journal
ISSN: 1348-4540
Titre abrégé: Endocr J
Pays: Japan
ID NLM: 9313485

Informations de publication

Date de publication:
28 May 2019
Historique:
pubmed: 15 3 2019
medline: 24 12 2019
entrez: 15 3 2019
Statut: ppublish

Résumé

We studied cytological specimens of conventional papillary thyroid carcinoma (PTC), follicular variant papillary thyroid carcinoma (FVPTC), and noninvasive follicular thyroid tumor with papillary-like nuclear features (NIFTP) (formerly noninvasive FVPTC) to identify useful cytological parameters for their differentiation. Cytological findings of invasive FVPTC and NIFTP were very similar to each other but differed from those of conventional PTC. Intranuclear cytoplasmic inclusions, true papillary cell clusters, monolayered cell sheets, ropy colloids, multinucleate giant cells, psammoma bodies, and cystic background were the observed characteristic features of conventional PTC. Microfollicular cell clusters and dense globules of colloids were characteristic features of invasive FVPTC and NIFTP. Scoring the eight parameters (intranuclear cytoplasmic inclusions, nuclear grooves, powdery chromatin, true papillary cell clusters, ropy colloids, multinucleate giant cells, psammoma bodies, and cystic background) readily distinguished NIFTP from conventional PTC, but could not distinguish NIFTP from invasive FVPTC. The average total score of NIFTP, invasive FVPTC, and conventional PTC were 2.60 ± 0.55, 2.63 ± 0.62, and 4.57 ± 0.99, respectively. The difference between conventional PTC and NIFTP or invasive FVPTC was statistically significant (p < 0.001, Student's t-test). Individuals with more than three of the identified parameters likely harbor conventional PTC, rather than NIFTP. In this way, 87.5% (112/128) of conventional PTCs could be differentiated from NIFTP, and definitively diagnosed as malignant by cytology.

Identifiants

pubmed: 30867345
doi: 10.1507/endocrj.EJ18-0525
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

475-483

Auteurs

Takashi Koshikawa (T)

Department of Pathology, Shubun University Faculty of Nursing, Ichinomiya 491-0938, Japan.
Department of Clinical Laboratories, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.

Nao Fujita (N)

Department of Clinical Laboratories, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.

Nanae Ueda (N)

Department of Clinical Laboratories, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.

Yuko Ota (Y)

Department of Clinical Laboratories, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.

Eiichi Sasaki (E)

Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.

Yoshiko Murakami (Y)

Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.

Waki Hosoda (W)

Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.

Yasushi Yatabe (Y)

Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.

Nobuhiro Hanai (N)

Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan.

Miyoko Higuchi (M)

Department of Laboratory Medicine, Kuma Hospital, Kobe 856-8562, Japan.

Mitsuyoshi Hirokawa (M)

Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe 856-8562, Japan.

Akira Miyauchi (A)

Department of Surgery, Kuma Hospital, Kobe 856-8562, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH